Arch Therapeutics, Inc. (OTCQB: ARTH), developer of the AC5 Surgical Hemostatic Device™, announced that it would be featured as a presenting company at The Biotech Showcase™ 2015 Conference on Wednesday, January 14, 2015 at 11:00 AM PST. The conference will be held at the Parc 55 Wyndham Hotel, located at Union Square, San Francisco, California.
http://bit.ly/1zvQgPf
No comments:
Post a Comment